Elucidating the molecular mechanism of noncompetitive inhibition of acetylcholinesterase by an antidiabetic drug chlorpropamide: identification of new allosteric sites

A new allosteric site has been identified in acetylcholinesterase (AChE) as a potential drug target. Binding of inhibitors modulates the conformational ensemble at the catalytic site.